NDC product
Magnesium Citrate
NDC 0363-0415 · WALGREEN COMPANY
Key facts
| Product NDC | 0363-0415 |
|---|---|
| Proprietary name | Magnesium Citrate |
| Nonproprietary name | Magnesium Citrate |
| Substances | MAGNESIUM CITRATE |
| Dosage form | LIQUID |
| Route | ORAL |
| Labeler | WALGREEN COMPANY |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M007 |
| Pharmacologic classes | Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA] and 2 more |
| Marketing start | Jan 31, 2023 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: